Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Aggressive Terminal Phase of Multiple Myeloma

Aggressive Terminal Phase of Multiple Myeloma Abstract To the Editor. —Bergsagel and Pruzanski1 described an acute terminal phase of multiple myeloma characterized by rapid growth of the tumor, fever, and pancytopenia. In the recent article published in the Archives by Suchman et al (1981;141:1315-1320), a new variant of the terminal phase is characterized, in addition to fever and pancytopenia, by rapidly enlarging soft-tissue masses, decreasing levels of myeloma proteins, and rapid death. This finding prompted us to review our series of 109 consecutive patients who had died of myeloma, and nine cases of this variant were found. Data of the patients are reported herein. Report of Cases. —The mean age of patients at the diagnosis of myeloma was 57 years. Five of the nine patients were women. The immunologic type of myeloma was IgG in six patients, IgA in two patients, and IgD in one patient. The median duration of the disease before the development of References 1. Bergsagel DE, Pruzanski W: Treatment of plasma cell myeloma with cytotoxic agents. Arch Intern Med 1975;135:172-176.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Aggressive Terminal Phase of Multiple Myeloma

Abstract

Abstract To the Editor. —Bergsagel and Pruzanski1 described an acute terminal phase of multiple myeloma characterized by rapid growth of the tumor, fever, and pancytopenia. In the recent article published in the Archives by Suchman et al (1981;141:1315-1320), a new variant of the terminal phase is characterized, in addition to fever and pancytopenia, by rapidly enlarging soft-tissue masses, decreasing levels of myeloma proteins, and rapid death. This finding prompted us to review our...
Loading next page...
 
/lp/american-medical-association/aggressive-terminal-phase-of-multiple-myeloma-VxnUVXGvRT
Publisher
American Medical Association
Copyright
Copyright © 1982 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1982.00340220183035
Publisher site
See Article on Publisher Site

Abstract

Abstract To the Editor. —Bergsagel and Pruzanski1 described an acute terminal phase of multiple myeloma characterized by rapid growth of the tumor, fever, and pancytopenia. In the recent article published in the Archives by Suchman et al (1981;141:1315-1320), a new variant of the terminal phase is characterized, in addition to fever and pancytopenia, by rapidly enlarging soft-tissue masses, decreasing levels of myeloma proteins, and rapid death. This finding prompted us to review our series of 109 consecutive patients who had died of myeloma, and nine cases of this variant were found. Data of the patients are reported herein. Report of Cases. —The mean age of patients at the diagnosis of myeloma was 57 years. Five of the nine patients were women. The immunologic type of myeloma was IgG in six patients, IgA in two patients, and IgD in one patient. The median duration of the disease before the development of References 1. Bergsagel DE, Pruzanski W: Treatment of plasma cell myeloma with cytotoxic agents. Arch Intern Med 1975;135:172-176.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Sep 1, 1982

References